Release Date: 06/06/22 08:22 Summary: ACCC extends review of proposed acquisition Price Sensitive: Yes Download Document 98.01KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%